
Predictive Oncology Inc.
NASDAQ:POAI
1.4 (USD) • At close April 2, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Predictive Oncology Inc. |
Symbool | POAI |
Munteenheid | USD |
Prijs | 1.4 |
Beurswaarde | 10,093,580 |
Dividendpercentage | 0% |
52-weken bereik | 0.55 - 3.06 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Raymond F. Vennare |
Website | https://www.predictive-oncology.com |
An error occurred while fetching data.
Over Predictive Oncology Inc.
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)